Last 12 months
Inside the activity.
0 purchase rows · 12 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 03, 2023 Filed May 5, 2023 20:53 UTC |
Evens DeirdreDirector
|
GrantRestricted Stock Grant · Derivative | 2,096 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000897069-23-000397 · form4.xml · derivative · entry 4 Evens Deirdre · CIK 0001401237 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,992 Underlying: Common Stock · 2,096 shares Expires not disclosed F4 · derivative.exercise_date: Shares vest 100% on the first anniversary of the date of grant. F4 · derivative.expiration_date: Shares vest 100% on the first anniversary of the date of grant. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:53 UTC |
Evens DeirdreDirector
|
Exercise / conversionCommon Stock | 79 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000897069-23-000397 · form4.xml · nonDerivative · entry 2 Evens Deirdre · CIK 0001401237 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,509 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Settlement of dividend equivalent rights in connection with vesting of restrictive stock. The rights accrued when and as dividends were paid on Regency's common stock and vested proportionately with the restricted stock. Each dividend equivalent is the equivalent of one share of Regency's common stock. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:53 UTC |
Evens DeirdreDirector
|
Exercise / conversionCommon Stock | 1,817 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000897069-23-000397 · form4.xml · nonDerivative · entry 1 Evens Deirdre · CIK 0001401237 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,430 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Vesting of restricted stock granted pursuant to Regency's Omnibus Incentive Plan. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:49 UTC |
Klein KarinDirector
|
Exercise / conversionDividend Equivalent Rights · Derivative | 79 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000897069-23-000395 · form4.xml · derivative · entry 6 Klein Karin · CIK 0001670481 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,096 Underlying: Common Stock · 79 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with vesting of restrictive stock. The rights accrued when and as dividends were paid on Regency's common stock and vested proportionately restricted stock. Each dividend equivalent is the equivalent of one share of Regency's common stock. F2 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with vesting of restrictive stock. The rights accrued when and as dividends were paid on Regency's common stock and vested proportionately restricted stock. Each dividend equivalent is the equivalent of one share of Regency's common stock. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:49 UTC |
Klein KarinDirector
|
Exercise / conversionRestricted Stock · Derivative | 1,817 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000897069-23-000395 · form4.xml · derivative · entry 5 Klein Karin · CIK 0001670481 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,175 Underlying: Common Stock · 1,817 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Vesting of restricted stock granted pursuant to Regency's Omnibus Incentive Plan. F1 · derivative.expiration_date: Vesting of restricted stock granted pursuant to Regency's Omnibus Incentive Plan. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:49 UTC |
Klein KarinDirector
|
GrantRestricted Stock Grant · Derivative | 2,096 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000897069-23-000395 · form4.xml · derivative · entry 4 Klein Karin · CIK 0001670481 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,992 Underlying: Common Stock · 2,096 shares Expires not disclosed F4 · derivative.exercise_date: Shares vest 100% on the first anniversary of the date of grant. F4 · derivative.expiration_date: Shares vest 100% on the first anniversary of the date of grant. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:49 UTC |
Klein KarinDirector
|
Exercise / conversionCommon Stock | 79 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000897069-23-000395 · form4.xml · nonDerivative · entry 2 Klein Karin · CIK 0001670481 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,893 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Settlement of dividend equivalent rights in connection with vesting of restrictive stock. The rights accrued when and as dividends were paid on Regency's common stock and vested proportionately restricted stock. Each dividend equivalent is the equivalent of one share of Regency's common stock. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:49 UTC |
Klein KarinDirector
|
Exercise / conversionCommon Stock | 1,817 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000897069-23-000395 · form4.xml · nonDerivative · entry 1 Klein Karin · CIK 0001670481 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Vesting of restricted stock granted pursuant to Regency's Omnibus Incentive Plan. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:47 UTC |
LINNEMAN PETERDirector
|
Exercise / conversionDividend Equivalent Rights · Derivative | 79 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000897069-23-000393 · form4.xml · derivative · entry 6 LINNEMAN PETER · CIK 0001170994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,096 Underlying: Common Stock · 79 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with vesting of restrictive stock. The rights accrued when and as dividends were paid on Regency's common stock and vested proportionately with the restricted stock. Each dividend equivalent is the equivalent of one share of Regency's common stock. F2 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with vesting of restrictive stock. The rights accrued when and as dividends were paid on Regency's common stock and vested proportionately with the restricted stock. Each dividend equivalent is the equivalent of one share of Regency's common stock. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:47 UTC |
LINNEMAN PETERDirector
|
Exercise / conversionRestricted Stock · Derivative | 1,817 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000897069-23-000393 · form4.xml · derivative · entry 5 LINNEMAN PETER · CIK 0001170994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,175 Underlying: Common Stock · 1,817 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Vesting of restricted stock granted pursuant to Regency's Omnibus Incentive Plan. F1 · derivative.expiration_date: Vesting of restricted stock granted pursuant to Regency's Omnibus Incentive Plan. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:47 UTC |
LINNEMAN PETERDirector
|
GrantRestricted Stock Grant · Derivative | 2,096 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000897069-23-000393 · form4.xml · derivative · entry 4 LINNEMAN PETER · CIK 0001170994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,992 Underlying: Common Stock · 2,096 shares Expires not disclosed F4 · derivative.exercise_date: Shares vest 100% on the first anniversary of the date of grant. F4 · derivative.expiration_date: Shares vest 100% on the first anniversary of the date of grant. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:47 UTC |
LINNEMAN PETERDirector
|
Exercise / conversionCommon Stock | 79 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000897069-23-000393 · form4.xml · nonDerivative · entry 2 LINNEMAN PETER · CIK 0001170994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Settlement of dividend equivalent rights in connection with vesting of restrictive stock. The rights accrued when and as dividends were paid on Regency's common stock and vested proportionately with the restricted stock. Each dividend equivalent is the equivalent of one share of Regency's common stock. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:47 UTC |
LINNEMAN PETERDirector
|
Exercise / conversionCommon Stock | 1,817 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000897069-23-000393 · form4.xml · nonDerivative · entry 1 LINNEMAN PETER · CIK 0001170994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,958 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Vesting of restricted stock granted pursuant to Regency's Omnibus Incentive Plan. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:45 UTC |
OCONNOR DAVID PDirector
|
Exercise / conversionDividend Equivalent Rights · Derivative | 79 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000897069-23-000391 · form4.xml · derivative · entry 5 OCONNOR DAVID P · CIK 0001275853 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,096 Underlying: Common Stock · 79 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with vesting of restrictive stock. The rights accrued when and as dividends were paid on Regency's common stock and vested proportionately with the restricted stock. Each dividend equivalent is the equivalent of one share of Regency's common stock. F2 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with vesting of restrictive stock. The rights accrued when and as dividends were paid on Regency's common stock and vested proportionately with the restricted stock. Each dividend equivalent is the equivalent of one share of Regency's common stock. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:45 UTC |
OCONNOR DAVID PDirector
|
Exercise / conversionRestricted Stock · Derivative | 1,817 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000897069-23-000391 · form4.xml · derivative · entry 4 OCONNOR DAVID P · CIK 0001275853 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,175 Underlying: Common Stock · 1,817 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Vesting of restricted stock grant pursuant to Regency's Omnibus Incentive Plan. F1 · derivative.expiration_date: Vesting of restricted stock grant pursuant to Regency's Omnibus Incentive Plan. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:45 UTC |
OCONNOR DAVID PDirector
|
GrantRestricted Stock Grant · Derivative | 2,096 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000897069-23-000391 · form4.xml · derivative · entry 3 OCONNOR DAVID P · CIK 0001275853 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,992 Underlying: Common Stock · 2,096 shares Expires not disclosed F3 · derivative.exercise_date: Shares vest 100% on the first anniversary of the date of grant. F3 · derivative.expiration_date: Shares vest 100% on the first anniversary of the date of grant. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:45 UTC |
OCONNOR DAVID PDirector
|
Exercise / conversionCommon Stock | 79 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000897069-23-000391 · form4.xml · nonDerivative · entry 2 OCONNOR DAVID P · CIK 0001275853 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Settlement of dividend equivalent rights in connection with vesting of restrictive stock. The rights accrued when and as dividends were paid on Regency's common stock and vested proportionately with the restricted stock. Each dividend equivalent is the equivalent of one share of Regency's common stock. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:45 UTC |
OCONNOR DAVID PDirector
|
Exercise / conversionCommon Stock | 1,817 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000897069-23-000391 · form4.xml · nonDerivative · entry 1 OCONNOR DAVID P · CIK 0001275853 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Vesting of restricted stock grant pursuant to Regency's Omnibus Incentive Plan. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:43 UTC |
BLAIR BRYCEDirector
|
Exercise / conversionDividend Equivalent Rights · Derivative | 79 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000897069-23-000389 · form4.xml · derivative · entry 5 BLAIR BRYCE · CIK 0001219691 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,096 Underlying: Common Stock · 79 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with vesting of restrictive stock. The rights accrued when and as dividends were paid on Regency's common stock and vested proportionately with the restricted stock. Each dividend equivalent is the equivalent of one share of Regency's common stock. F2 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with vesting of restrictive stock. The rights accrued when and as dividends were paid on Regency's common stock and vested proportionately with the restricted stock. Each dividend equivalent is the equivalent of one share of Regency's common stock. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:43 UTC |
BLAIR BRYCEDirector
|
Exercise / conversionRestricted Stock · Derivative | 1,817 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000897069-23-000389 · form4.xml · derivative · entry 4 BLAIR BRYCE · CIK 0001219691 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,175 Underlying: Common Stock · 1,817 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Vesting of restricted stock grant pursuant to Regency's Omnibus Incentive Plan. F1 · derivative.expiration_date: Vesting of restricted stock grant pursuant to Regency's Omnibus Incentive Plan. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:43 UTC |
BLAIR BRYCEDirector
|
GrantRestricted Stock Grant · Derivative | 2,096 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000897069-23-000389 · form4.xml · derivative · entry 3 BLAIR BRYCE · CIK 0001219691 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,992 Underlying: Common Stock · 2,096 shares Expires not disclosed F3 · derivative.exercise_date: Shares vest 100% on the first anniversary of the date of grant. F3 · derivative.expiration_date: Shares vest 100% on the first anniversary of the date of grant. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:43 UTC |
BLAIR BRYCEDirector
|
Exercise / conversionCommon Stock | 79 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000897069-23-000389 · form4.xml · nonDerivative · entry 2 BLAIR BRYCE · CIK 0001219691 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,769.21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Settlement of dividend equivalent rights in connection with vesting of restrictive stock. The rights accrued when and as dividends were paid on Regency's common stock and vested proportionately with the restricted stock. Each dividend equivalent is the equivalent of one share of Regency's common stock. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:43 UTC |
BLAIR BRYCEDirector
|
Exercise / conversionCommon Stock | 1,817 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000897069-23-000389 · form4.xml · nonDerivative · entry 1 BLAIR BRYCE · CIK 0001219691 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,690.21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Vesting of restricted stock grant pursuant to Regency's Omnibus Incentive Plan. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:39 UTC |
Simmons James H. IIIDirector
|
Exercise / conversionDividend Equivalent Rights · Derivative | 79 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000897069-23-000387 · form4.xml · derivative · entry 5 Simmons James H. III · CIK 0001825185 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,096 Underlying: Common Stock · 79 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with vesting of restricted stock. The rights accrued when and as dividends were paid on Regency's common stock and vested proportionately with the restricted stock. Each dividend equivalent is the equivalent of one share of Regency's common stock. F2 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with vesting of restricted stock. The rights accrued when and as dividends were paid on Regency's common stock and vested proportionately with the restricted stock. Each dividend equivalent is the equivalent of one share of Regency's common stock. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:39 UTC |
Simmons James H. IIIDirector
|
Exercise / conversionRestricted Stock · Derivative | 1,817 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000897069-23-000387 · form4.xml · derivative · entry 4 Simmons James H. III · CIK 0001825185 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,175 Underlying: Common Stock · 1,817 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Vesting of restricted stock granted pursuant to Regency's Omnibus Incentive Plan. F1 · derivative.expiration_date: Vesting of restricted stock granted pursuant to Regency's Omnibus Incentive Plan. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:39 UTC |
Simmons James H. IIIDirector
|
GrantRestricted Stock Grant · Derivative | 2,096 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000897069-23-000387 · form4.xml · derivative · entry 3 Simmons James H. III · CIK 0001825185 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,992 Underlying: Common Stock · 2,096 shares Expires not disclosed F3 · derivative.exercise_date: Shares vest 100% on the first anniversary of the date of grant F3 · derivative.expiration_date: Shares vest 100% on the first anniversary of the date of grant Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:39 UTC |
Simmons James H. IIIDirector
|
Exercise / conversionCommon Stock | 79 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000897069-23-000387 · form4.xml · nonDerivative · entry 2 Simmons James H. III · CIK 0001825185 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Settlement of dividend equivalent rights in connection with vesting of restricted stock. The rights accrued when and as dividends were paid on Regency's common stock and vested proportionately with the restricted stock. Each dividend equivalent is the equivalent of one share of Regency's common stock. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:39 UTC |
Simmons James H. IIIDirector
|
Exercise / conversionCommon Stock | 1,817 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000897069-23-000387 · form4.xml · nonDerivative · entry 1 Simmons James H. III · CIK 0001825185 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,817 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Vesting of restricted stock granted pursuant to Regency's Omnibus Incentive Plan. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:36 UTC |
BLANKENSHIP C RONALDDirector
|
Exercise / conversionDividend Equivalent Rights · Derivative | 85 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000897069-23-000385 · form4.xml · derivative · entry 6 BLANKENSHIP C RONALD · CIK 0001171118 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,263 Underlying: Common Stock · 85 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with vesting of restricted stock. The rights accrued when and as dividends were paid on Regency's common stock and vested proportionately with the restricted stock. Each dividend equivalent is the equivalent of one share of Regency's common stock. F3 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with vesting of restricted stock. The rights accrued when and as dividends were paid on Regency's common stock and vested proportionately with the restricted stock. Each dividend equivalent is the equivalent of one share of Regency's common stock. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:36 UTC |
BLANKENSHIP C RONALDDirector
|
Exercise / conversionRestricted Stock · Derivative | 1,962 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000897069-23-000385 · form4.xml · derivative · entry 5 BLANKENSHIP C RONALD · CIK 0001171118 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,348 Underlying: Common Stock · 1,962 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Vesting of restricted stock granted pursuant to Regency's Omnibus Incentive Plan. F2 · derivative.exercise_date: The previous filing inadvertently underreported the number of restricted stock granted to the Reporting Person by 131 shares. This filing properly reflects the correct number of shares as of May 5, 2023. F1 · derivative.expiration_date: Vesting of restricted stock granted pursuant to Regency's Omnibus Incentive Plan. F2 · derivative.expiration_date: The previous filing inadvertently underreported the number of restricted stock granted to the Reporting Person by 131 shares. This filing properly reflects the correct number of shares as of May 5, 2023. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:36 UTC |
BLANKENSHIP C RONALDDirector
|
GrantRestricted Stock Grant · Derivative | 2,263 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000897069-23-000385 · form4.xml · derivative · entry 4 BLANKENSHIP C RONALD · CIK 0001171118 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,310 Underlying: Common Stock · 2,263 shares Expires not disclosed F5 · derivative.exercise_date: Shares vest 100% on the first anniversary of the date of grant. F5 · derivative.expiration_date: Shares vest 100% on the first anniversary of the date of grant. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:36 UTC |
BLANKENSHIP C RONALDDirector
|
Exercise / conversionCommon Stock | 85 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000897069-23-000385 · form4.xml · nonDerivative · entry 2 BLANKENSHIP C RONALD · CIK 0001171118 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Settlement of dividend equivalent rights in connection with vesting of restricted stock. The rights accrued when and as dividends were paid on Regency's common stock and vested proportionately with the restricted stock. Each dividend equivalent is the equivalent of one share of Regency's common stock. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:36 UTC |
BLANKENSHIP C RONALDDirector
|
Exercise / conversionCommon Stock | 1,962 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000897069-23-000385 · form4.xml · nonDerivative · entry 1 BLANKENSHIP C RONALD · CIK 0001171118 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Vesting of restricted stock granted pursuant to Regency's Omnibus Incentive Plan. F2 · price: The previous filing inadvertently underreported the number of restricted stock granted to the Reporting Person by 131 shares. This filing properly reflects the correct number of shares as of May 5, 2023. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:47 UTC |
HERMAN MICHAEL RSenior VP and General Counsel
|
GrantRestricted Stock Grant · Derivative | 4,887 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-004513 · doc1.xml · derivative · entry 1 HERMAN MICHAEL R · CIK 0001264140 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,887 Underlying: Common Stock · 4,887 shares Expires not disclosed F1 · derivative.exercise_date: Shares vest 25% per year begining February 2, 2024. F1 · derivative.expiration_date: Shares vest 25% per year begining February 2, 2024. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:49 UTC |
LEAVITT J CHRISTIANChief Accounting Officer
|
GrantRestricted Stock Grant · Derivative | 4,265 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-004516 · doc1.xml · derivative · entry 1 LEAVITT J CHRISTIAN · CIK 0001190609 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,265 Underlying: Common Stock · 4,265 shares Expires not disclosed F1 · derivative.exercise_date: Shares vest 25% per year begining February 2, 2024. F1 · derivative.expiration_date: Shares vest 25% per year begining February 2, 2024. Read SEC document |
| February 21, 2023 Filed Feb 22, 2023 21:47 UTC |
STEIN MARTIN E JRDirector · Executive Chairman
|
GiftCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-003515 · doc1.xml · nonDerivative · entry 1 STEIN MARTIN E JR · CIK 0001171042 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468,399 Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:39 UTC |
PALMER LISADirector · President and CEO
|
GiftCommon Stock | 7,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-003175 · doc1.xml · nonDerivative · entry 2 PALMER LISA · CIK 0001564501 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,000 Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:39 UTC |
PALMER LISADirector · President and CEO
|
SaleCommon Stock | 15,180 | $65.58 | $995,504.40 |
DisclosureSEC source: 0001567619-23-003175 · doc1.xml · nonDerivative · entry 1 PALMER LISA · CIK 0001564501 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,000 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.51 to $65.71, inclusive. The Reporting Person undertakes to provide Regency Centers Corp (the "Company"), any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| February 09, 2023 Filed Feb 9, 2023 22:05 UTC |
WIBBENMEYER NICHOLAS ANDREWEVP, W. Regional Pres.
|
GrantRestricted Stock · Derivative | 4,443 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-002181 · doc1.xml · derivative · entry 6 WIBBENMEYER NICHOLAS ANDREW · CIK 0001662981 · EVP, W. Regional Pres. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,443 Underlying: Common Stock · 4,443 shares Expires not disclosed F3 · derivative.exercise_price: Shares vest 25% annually begining February 9, 2024. F3 · derivative.exercise_date: Shares vest 25% annually begining February 9, 2024. F3 · derivative.expiration_date: Shares vest 25% annually begining February 9, 2024. Read SEC document |
| February 09, 2023 Filed Feb 9, 2023 22:03 UTC |
ROTH ALAN TODDEVP, E. Regional Pres.
|
GrantRestricted Stock · Derivative | 4,443 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-002179 · doc1.xml · derivative · entry 7 ROTH ALAN TODD · CIK 0001662980 · EVP, E. Regional Pres. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,443 Underlying: Common Stock · 4,443 shares Expires not disclosed F3 · derivative.exercise_price: Shares vest 25% annually beginning February 9, 2024. F3 · derivative.exercise_date: Shares vest 25% annually beginning February 9, 2024. F3 · derivative.expiration_date: Shares vest 25% annually beginning February 9, 2024. Read SEC document |
| February 09, 2023 Filed Feb 9, 2023 22:00 UTC |
MAS MICHAEL JEVP and CFO
|
GrantRestricted Stock · Derivative | 5,035 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-002173 · doc1.xml · derivative · entry 5 MAS MICHAEL J · CIK 0001698658 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,035 Underlying: Common Stock · 5,035 shares Expires not disclosed F3 · derivative.exercise_price: Shares vest 25% annually beginning February 9, 2024. F3 · derivative.exercise_date: Shares vest 25% annually beginning February 9, 2024. F3 · derivative.expiration_date: Shares vest 25% annually beginning February 9, 2024. Read SEC document |
| February 08, 2023 Filed Feb 8, 2023 21:39 UTC |
LINNEMAN PETERDirector
|
GrantCommon Stock | 407 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-23-002089 · doc1.xml · nonDerivative · entry 1 LINNEMAN PETER · CIK 0001170994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,141 F1 · price: Represents director's fees paid in stock pursuant to Regency's Omnibus Incentive Plan. Read SEC document |
| February 08, 2023 Filed Feb 8, 2023 21:38 UTC |
Evens DeirdreDirector
|
GrantCommon Stock | 468 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-23-002088 · doc1.xml · nonDerivative · entry 1 Evens Deirdre · CIK 0001401237 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,613 F1 · price: Represents director's fees paid in stock pursuant to Regency's Omnibus Incentive Plan. Read SEC document |
| February 08, 2023 Filed Feb 8, 2023 21:37 UTC |
Klein KarinDirector
|
GrantCommon Stock | 407 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-23-002087 · doc1.xml · nonDerivative · entry 1 Klein Karin · CIK 0001670481 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,997 F1 · price: Represents director's fees paid in stock pursuant to Regency's Omnibus Incentive Plan. Read SEC document |
| February 08, 2023 Filed Feb 8, 2023 21:36 UTC |
BLANKENSHIP C RONALDDirector
|
GrantCommon Stock | 570 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-23-002086 · doc1.xml · nonDerivative · entry 1 BLANKENSHIP C RONALD · CIK 0001171118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,463 F1 · price: Represents director's fees paid in stock pursuant to Regency's Omnibus Incentive Plan. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 22:10 UTC |
PALMER LISADirector · President and CEO
|
Exercise / conversionDividend Equivalents · Derivative | 217 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-002184 · doc1.xml · derivative · entry 5 PALMER LISA · CIK 0001564501 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 217 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Includes 8,674 shares accrued when and as dividends were paid on Regency Centers Corporation common Stock and vested with the performance shares to which they relate. F1 · derivative.exercise_date: Includes 8,674 shares accrued when and as dividends were paid on Regency Centers Corporation common Stock and vested with the performance shares to which they relate. F1 · derivative.expiration_date: Includes 8,674 shares accrued when and as dividends were paid on Regency Centers Corporation common Stock and vested with the performance shares to which they relate. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 22:10 UTC |
PALMER LISADirector · President and CEO
|
GrantRestricted Stock · Derivative | 15,845 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-002184 · doc1.xml · derivative · entry 4 PALMER LISA · CIK 0001564501 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,845 Underlying: Common Stock · 15,845 shares Expires not disclosed F3 · derivative.exercise_price: Shares vest 25% annually beginning February 7, 2024. F3 · derivative.exercise_date: Shares vest 25% annually beginning February 7, 2024. F3 · derivative.expiration_date: Shares vest 25% annually beginning February 7, 2024. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 22:10 UTC |
PALMER LISADirector · President and CEO
|
Exercise / conversionRestricted Stock · Derivative | 2,716 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-002184 · doc1.xml · derivative · entry 3 PALMER LISA · CIK 0001564501 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,866 Underlying: Common Stock · 2,716 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Vesting of performance shares and restricted stock. F2 · derivative.exercise_date: Vesting of performance shares and restricted stock. F2 · derivative.expiration_date: Vesting of performance shares and restricted stock. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 22:10 UTC |
PALMER LISADirector · President and CEO
|
Tax withholdingCommon Stock | 30,653 | $66.78 | $2,047,007.34 |
DisclosureSEC source: 0001567619-23-002184 · doc1.xml · nonDerivative · entry 2 PALMER LISA · CIK 0001564501 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,180 Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 22:10 UTC |
PALMER LISADirector · President and CEO
|
Exercise / conversionCommon Stock | 77,744 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-23-002184 · doc1.xml · nonDerivative · entry 1 PALMER LISA · CIK 0001564501 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Includes 8,674 shares accrued when and as dividends were paid on Regency Centers Corporation common Stock and vested with the performance shares to which they relate. F2 · price: Vesting of performance shares and restricted stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.